title: Cerebral hemorrhage following thrombolytic therapy for stroke: Are neutrophils really neutral?
authors.affiliation: From the Department of Clinical Research (L.R.), Federal University of Uberlândia, Brazil; the Stroke Center/Department of Neurology (S.R.L.), The State University of New York (SUNY) Health Science Center at Brooklyn, Downstate Medical Center Brooklyn; and the Department of Neurology (S.R.L.), Kings County Hospital Center, Brooklyn, NY. leonardoroever@hotmail.com.
authors.forename: Leonardo
authors.initials: L
authors.lastname: Roever
authors.affiliation: From the Department of Clinical Research (L.R.), Federal University of Uberlândia, Brazil; the Stroke Center/Department of Neurology (S.R.L.), The State University of New York (SUNY) Health Science Center at Brooklyn, Downstate Medical Center Brooklyn; and the Department of Neurology (S.R.L.), Kings County Hospital Center, Brooklyn, NY.
authors.forename: Steven R
authors.initials: SR
authors.lastname: Levine
mesh_terms: D002545:Brain Ischemia / Q000097:blood* / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000097:blood* / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D009504:Neutrophils / Q000378:metabolism*; D015912:Thrombolytic Therapy / Q000009:adverse effects*